Synergistic Impact Of Combined Zoledronic Acid / 5-FU And Zoledronic Acid / Flutamide On The Expression Of MiR-382, MiR-18a, Bcl - 2 And P53 In PC- 3 Cancer Cells.
Introduction/Aims: assessment of the chemotherapeutic effect of zoledronic acid (ZA) when combined with 5-FU or Flutamide on prostate cancer cell line (PC-3), through estimation of synergistic effects

